Article
The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer
8 Dec 2006
Abstract excerpt
The retinoblastoma tumor suppressor (RB) protein is functionally inactivated in the majority of human cancers and is aberrant in one-third of all breast cancers. RB regulates G(1)/S-phase cell-cycle progression and is a critical mediator of antiproliferative signaling. Here the specific impact of RB deficiency on E2F-regulated gene expression, tumorigenic proliferation, and the response to 2 distinct lines of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
